High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.6M
$1,576,095
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Other
|
2025-11-13 | $154,868x2 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Gold Alexander M
• Director
Discretionary Sell
2025-11-13
$592,503
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-11-13 | $592,503 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Other
|
2025-11-12 | $70,717 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Gold Alexander M
• Director
Discretionary SellΔOwn -72.1%
2025-11-12
$323,886x2
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Discretionary SellΔOwn -72.1%
|
2025-11-12 | $323,886x2 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Other
|
2025-11-11 | $153,000 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Gold Alexander M
• Director
Discretionary SellΔOwn -66.7%
2025-11-11
$659,706x2
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Discretionary SellΔOwn -66.7%
|
2025-11-11 | $659,706x2 | S | Form 4 |